Future? Produces plant-based medicine. They’re smart, likes the management team because of their pharma experience. Oversupply still to get through, but if you’re willing to look beyond the next year, stick with it. If you’re worried about storm clouds, put your money into a high-yielding energy stock, or another commodity, and then come back in later in 2019.
He thinks the smaller and intermediate producers are going to have a tough time making money in weed as the big 4 continue to lower costs and raise capital at lower costs.
It does look interesting. They have an expansion plan. He thinks the caller might be onto something. He would not run out and buy it because the valuation is still $150 Million.
ABcann Global Corp. is a OTC stock, trading under the symbol ABCN-X on the (). It is usually referred to as or ABCN-X
In the last year, there was no coverage of ABcann Global Corp. published on Stockchase.
ABcann Global Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for ABcann Global Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of ABcann Global Corp. published on Stockchase.
On , ABcann Global Corp. (ABCN-X) stock closed at a price of $.